微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 4.47% | -8.59% | 53.61% | 66/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 2.91% | -19.61% | 91.45% | 65/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 1.52% | -11.63% | -36.93% | 74/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 2.41% | -39.9% | -50.72% | 84/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 4.89% | -29.34% | 35.08% | 73/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 3.62% | -32.46% | 110.47% | 58/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 1.72% | 4.24% | -57.11% | 68/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 4.01% | -36.25% | -42.05% | 83/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 6.92% | 28.39% | 29.1% | 54/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 5.36% | 53.58% | 224.85% | 45/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 1.65% | 30.95% | -73.77% | 69/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 6.29% | 5.18% | 16.7% | 68/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 5.39% | -0.19% | 54.44% | 77/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 3.49% | 13.68% | 176.98% | 74/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 1.26% | 43.18% | -78.93% | 88/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 5.98% | 9.32% | 10.74% | 79/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 5.4% | -2.35% | 75.9% | 68/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 3.07% | 3.02% | 248.86% | 75/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 0.88% | -20% | -83.91% | 72/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 5.47% | 5.39% | -1.08% | 84/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 5.53% | 9.94% | 85.57% | 63/160 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 2.98% | -2.93% | 170.91% | 73/160 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 1.1% | 10% | -78.81% | 83/160 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 5.19% | 24.76% | 3.18% | 85/160 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 5.03% | 6.57% | 63.84% | 69/160 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 3.07% | -4.36% | 207% | 67/160 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 1% | -32.89% | -75.96% | 77/160 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 4.16% | -28.28% | -11.86% | 91/160 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 4.72% | -25.2% | 47.04% | 66/160 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 3.21% | -21.52% | 115.44% | 71/160 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 1.49% | -20.74% | -74.31% | 53/160 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 5.8% | -35.7% | -8.08% | 78/160 | 6.33% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 6.31% | -25.5% | 54.28% | 42/160 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 4.09% | -26.7% | 117.55% | 47/160 | 3.53% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 1.88% | -34.95% | -79.16% | 43/160 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 9.02% | 7.64% | 6.49% | 55/160 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 8.47% | 7.08% | 51.79% | 32/160 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 5.58% | -3.13% | 93.08% | 32/160 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 2.89% | 50.52% | -65.51% | 30/160 | 2.41% | 华东医药 | 26.63% | 行业排名> |